B. Zhang

发表

A Missense Mutation of the Nitric Oxide Synthase (eNOS) Gene (Glu298Asp) in Five Patients with Coronary Artery Disease

K. Arakawa, S. Jimi, K. Saku, 1999, Angiology.

Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).

K. Arakawa, K. Saku, K. Shirai, 1999, Japanese circulation journal.

Combined therapy with probucol and pravastatin in hypercholesterolaemia

K. Arakawa, K. Saku, H. Bai, 1993, European Journal of Clinical Pharmacology.

Combined effects of probucol and benzafibrate on lipoprotein metabolism and liver cholesteryl ester transfer protein mRNA in cholesterol-fed rabbits.

K. Arakawa, S. Jimi, K. Saku, 1999, Japanese circulation journal.

Mechanism of action of probucol on cholesteryl ester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene.

H. Pownall, K. Arakawa, S. Jimi, 1998, Biochimica et biophysica acta.

Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.

K. Arakawa, K. Saku, T. Ohta, 1999, Journal of the American College of Cardiology.

In vivo kinetics of lipoprotein(a) in homozygous Watanabe heritable hyperlipidaemic rabbits

K. Arakawa, K. Saku, M. Shiomi, 1993, European journal of clinical investigation.

Serum lipoprotein (a) levels in maintenance hemodialysis patients.

K. Arakawa, K. Saku, G. Kajiyama, 1993, Nephron.

Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.

K. Arakawa, S. Jimi, K. Saku, 1993, Kidney international.

Insulin resistance observed in WHHL rabbits.

R. Liu, K. Arakawa, K. Saku, 1991, Atherosclerosis.

Long-term administration of probucol and QTc interval prolongation.

K. Arakawa, K. Saku, N. Sasaki, 1993, Artery.

Efficient nuclear delivery of antisense oligodeoxynucleotides and selective inhibition of CETP expression by apo E peptide in a human CETP-stably transfected CHO cell line.

L. Smith, H. Pownall, K. Arakawa, 1999, Arteriosclerosis, thrombosis, and vascular biology.

In vivo metabolism of HDL, apo A-I, and lp A-I, and function of HDL--a clinical perspective.

K. Saku, T. Ohta, B. Zhang, 2000, Journal of atherosclerosis and thrombosis.

The associations among thoracic aortic atherosclerosis, coronary atherosclerosis and the function of high density lipoprotein.

K. Saku, P. Fan, M. Takao, 2001, Atherosclerosis.

Hyperinsulinemic hypoalphalipoproteinemia as a new indicator for coronary heart disease.

K. Arakawa, S. Jimi, K. Saku, 1999, Journal of the American College of Cardiology.

High-density lipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probucol and bezafibrate

K. Arakawa, S. Jimi, K. Saku, 2004, European Journal of Clinical Pharmacology.

The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction.

K. Saku, T. Serikawa, P. Fan, 2001, Japanese circulation journal.

Insulin resistance and angiographical characteristics of coronary atherosclerosis.

K. Arakawa, K. Saku, K. Shirai, 1999, Japanese circulation journal.

Angiotensin I converting enzyme gene polymorphism and insulin resistance in patients with angina pectoris.

K. Arakawa, S. Jimi, K. Saku, 1999, American journal of hypertension.

Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli.

K. Arakawa, S. Jimi, K. Saku, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Levels of soluble cell adhesion molecules in patients with angiographically defined coronary atherosclerosis.

K. Arakawa, K. Saku, Y. Tsuchiya, 1999, Japanese circulation journal.

The I allele of the angiotensin‐converting enzyme gene is associated with an increased percentage of slow‐twitch type I fibers in human skeletal muscle

S. Miura, K. Saku, A. Kiyonaga, 2003, Clinical genetics.

Association of angiotensin‐converting‐enzyme gene polymorphism with the depressor response to mild exercise therapy in patients with mild to moderate essential hypertension

Hiroaki Tanaka, K. Saku, T. Sakai, 2002, Clinical genetics.

In vitro conversion of recombinant human proapolipoprotein A-I to apolipoprotein A-I.

K. Arakawa, K. Saku, K. Hirata, 1994, Biochimica et biophysica acta.

Effects of Chinese herbal drugs on serum lipids, lipoproteins and apolipoproteins in mild to moderate essential hypertensive patients.

K. Arakawa, K. Saku, K. Yoshinaga, 1992, Journal of human hypertension.

Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits.

K. Arakawa, K. Saku, T. Ohta, 1997, American journal of hypertension.

Quantification of the effects of troglitazone on insulin sensitivity and beta-cell function in Watanabe heritable hyperlipidemic rabbits: a minimal model analysis.

K. Arakawa, K. Saku, B. Zhang, 1997, Metabolism: clinical and experimental.

Quantitative characterization of insulin-glucose response in Watanabe heritable hyperlipidemic and cholesterol-fed rabbits and the effect of cilazapril.

K. Arakawa, K. Saku, M. Shiomi, 1994, Metabolism: clinical and experimental.

In vivo kinetics of oxidatively modified HDL.

K. Arakawa, K. Saku, M. Shiomi, 1993, Biochemical medicine and metabolic biology.

Paraoxonase (Pon1) Q192R polymorphism and serum Pon1 activity in diabetic patients on maintenance hemodialysis.

K. Saku, T. Saito, P. Fan, 2003, Clinical nephrology.

Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up.

K. Arakawa, K. Saku, T. Sakai, 1992, Clinical Therapeutics.